期刊文献+

血栓弹力图检测与常规凝血试验指导重症感染患者血浆输注的疗效对比分析 被引量:18

Comparative analysis on the curative effect of the plasma transfusion in patients with severe infection by thromboelastography or routine coagulation tests
下载PDF
导出
摘要 目的对比分析采用血栓弹力图(TEG)检测和常规凝血试验指导临床血浆输注的重症感染患者的预后及生存期的差异。方法在重症感染患者中选择血栓弹力图检测结果与常规凝血试验检测结果不一致的患者50例,分为2组:常规组,常规凝血试验结果指导血浆输注;TEG组,TEG检测结果指导血浆输注,追踪2组患者的临床预后及生存期的差异。结果重症感染患者均表现为APTT、PT、FDP、D-二聚体均明显升高,R时间正常或缩短,MA值明显增大(均为与正常参考值上限相比);TEG组生存期明显长于常规组(χ2=14.713,P<0.05)。结论重症感染患者的凝血试验结果与TEG检测结果不一致时,用TEG检测指导临床血浆输注,患者将获得更长的生存期,相关机制有待进一步探索。 Objective To analyze the differences in prognosis and survival by the use of thromboelastography( TEG) or routine coagulation test to guide clinical plasma infusion in patients with severe infection. Methods Fifty cases of severe infection patients,whose TEG test results were not consistent with the result of routine coagulation test,were chosen and divided into two groups. A control group was established according to the routine coagulation test results to guide the plasma infusion. A TEG group was established according to the testing results of TEG guidance plasma infusion. The clinical prognosis and survival differences of the two groups were analyzed. Results The APTT,PT,FDP and D-dimer were significantly higher than normal value,R-time was normal or shortened,and MA value increased notably( compared with the upper limit of normal reference value) in all selected patients with severe infection. The prognosis was significantly longer in TEG group than the control group( χ^2= 14. 713,P 〈0. 01). Conclusion Clinical plasma infusion should use TEG when coagulation test results are not consistent with TEG test results. Patients with severe infections will have longer prognoses. However,related mechanism needs further exploration.
作者 陈会欣 王顺
出处 《中国输血杂志》 CAS 北大核心 2016年第1期68-70,共3页 Chinese Journal of Blood Transfusion
基金 武汉市卫生计生委医疗卫生科研资助项目 项目编号WG13C20 湖北省卫生计生采供血专项资助项目 WJ2015CB006
关键词 重症感染 血栓弹力图检测 凝血试验 Severe infection thromboelastography routine coagulation tests
  • 相关文献

参考文献12

  • 1Weeder PD,Porte ILl, Lisman T. Hemostasis in liver disease: im- plications of new concepts for perioperative management. Transfus Meal Rev. 2014, 28(3):107-113.
  • 2Ton Lisman, Robert J. Rebalanced hemostasis in patients with liv- er disease: evidence and clinical consequences. Blood, 2010, 116 (6) : 878-885.
  • 3Petros S,Kliem P, Siegemund T,et al. Thrombin generation in se- vere sepsis. Thrombosis Research 2011, 129(6) : 797-800.
  • 4Mahla E, Lang T, Vicenzi MN, et al. Thrcmboleastography for- monitoring prolonged hyper coagulation after major abdominal sur- gery. Anesth Analg,2001,92(3) : 572-577.
  • 5McCrath DJ, Cerboni E, Frumento RJ, et al. Thromboelastography maximum amplitude predicts postoperative complications including myocardial infarction. Anesth Analg ,2005,100(6) : 1576-1583.
  • 6刘潇潇,刘双,米玉红,李雅敏.血栓弹力图评价严重脓毒症凝血功能紊乱的研究[J].心肺血管病杂志,2012,31(2):176-180. 被引量:13
  • 7Collins WJ, Macehiavello LI, Lewis S J, et al. Global tests of hae- mostasis in critically ill patients with severe sepsis syndrome com- pared to controls. Br J Haematol, 2006, 135(2) : 220-227.
  • 8KamathS, Lip GYH. Fibrinogen: biochemistry, epidemiology and determinants. QJM, 2003,96(10) : 711-729.
  • 9Lissalde-Lavlgne G, Combescure C, Muller L, et al. Simple coag- ulation tests improve survival prediction in patients with septic shock. Thromb Haemost, 2008, 6(4) : 645-653.
  • 10MUller MC, Straat M, Meijers JC, et al. Fresh frozen plasma trans- fusion fails to influence the hemostatic balance in critically ill pa- tients with acoagnlopathy. J Thromb Haemost. 2015, 13(6) :989- 970.

二级参考文献48

  • 1Marasco SF,Lukas G,McDonald M,et al.Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients.Heart Lung Circ,2008,17(Suppl 4),S41-47.
  • 2Brown KL,Goldman AP.Neonatal extra-corporeal life support,indications and limitations.Early Hum Dev,2008,84,143-148.
  • 3Schuerer DJ,Kolovos NS,Boyd KV,et al.Extracorporealmembrane oxygenation,current clinical practice,coding,and reimbursement.Chest,2008,134,179-184.
  • 4Haines NM,Rycus PT,Zwischenberger JB.Extracorporeallife support registry report 2008,neonatal and pediatriccardiac cases.ASAIO J,2009,55,111-116.
  • 5Conrad SA,Rycus PT,Dalton HJ,et al.Extracorporeal life support registry repport 2004.ASAIO J,2005,1,4-10.
  • 6Vercaemst L.Hemolysis in cardiac surgery patients undergoing cardiopulmonary bypass,a review in search of a treatment algorithm.J Extra Corpor Technol,2008,40,257 -267.
  • 7Alsoufi B,Al-Radi OO,Gruenwald C,et al.Extra-corporeal life support following cardiac surgery in children,analysis of risk factors and survival in a single institution.Eur J Cardiothorac Surg,2009,35,1004-1011.
  • 8Yap H J,Chen YC,Fang JT,et al.Combination of continuous renal replacement therapies (CRRT) and extraeorporeal membrahe oxygenation (ECMO)for advanced cardiac patients.Ren Fail,2003,25,183-193.
  • 9Golej J,Boigner H,Burda G,et al.Peritoneal dialysis for continuing renal support after cardiac ECMO and hemofiltration.Wien Klin Wochenschr,2002,114,733-738.
  • 10O Neill JM,Schutze GE,Heulitt MJ,et al.Nosocomjal infections during extracorpomal nlemb rane oxygenation.Intensive Care Med,2001,27,1247-1253.

共引文献71

同被引文献148

引证文献18

二级引证文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部